Price Alert

Lipocine Inc. (LPCN)

NASDAQ: LPCN · Real-Time Price · USD

3.04

0.00 (0.00%)

At close: Aug 15, 2025, 2:37 PM

0.00% (1D)

Bid	3
Market Cap	16.5M
Revenue (ttm)	4.21M
Net Income (ttm)	-4.51M
EPS (ttm)	-0.84
PE Ratio (ttm)	-3.62
Forward PE	-1.92
Analyst	Buy

Ask	3.06
Volume	6,089
Avg. Volume (20D)	51,622
Open	3.05
Previous Close	3.04
Day's Range	3.01 - 3.05
52-Week Range	2.68 - 6.17
Beta	1.24

About LPCN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LPCN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LPCN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Lipocine has released their quartely earnings on Aug 5, 2025:

Revenue of $622.85K exceeds estimates by $85.45K, with 595.42% YoY growth.

EPS of -0.41 exceeds estimates by 0.07, with 26.79% YoY growth.

Next Earnings Release

Lipocine Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

9 months ago

-7.76%

Lipocine shares are trading lower. The company rep... Unlock content with Pro Subscription

News

1 year ago · zacks.com

Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why

Lipocine (LPCN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

1 year ago · investorplace.com

7 Penny Biotech Stocks to Triple Your Investment

One of the oldest maxims in investing is that higher risk produces greater returns. That maxim holds particularly true across penny biotech stocks.

1 year ago · zacks.com

Here's Why Momentum in Lipocine (LPCN) Should Keep going

Lipocine (LPCN) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our s...